Shares of Apogee Therapeutics Inc. (APGE) have gained 41.4% over the past four weeks to close the last trading session at $55.7, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of$94.3 indicates a potential upside of 69.3%.The mean estimate comprises 10 short-term price targets with a standard deviation of $16.3. While the lowest estimate of$60.00 indicates a 7.7% increase from t ...